Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

BACKGROUND: Endostatin is a circulating endogenous angiogenesis inhibitor preventing neovascularization. Previous studies demonstrated the prognostic value of Endostatin among patients with heart failure with reduced ejection fraction (HFrEF). However, the role of Endostatin among patients with hear...

Descripción completa

Detalles Bibliográficos
Autores principales: Barroso, Michael Coll, Boehme, Philip, Kramer, Frank, Mondritzki, Thomas, Koehler, Till, Gülker, Jan-Erik, Karoff, Martin, Dinh, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729781/
https://www.ncbi.nlm.nih.gov/pubmed/28977054
http://dx.doi.org/10.5935/abc.20170144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729781/
https://www.ncbi.nlm.nih.gov/pubmed/28977054
http://dx.doi.org/10.5935/abc.20170144

Ejemplares similares